Cargando…
Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome
Mucopolysaccharidosis type I (MPS I) was added to the Recommended Uniform Screening Panel for newborn screening in 2016, highlighting recognition that early treatment of MPS I is critical to stem progressive, irreversible disease manifestations. Enzyme replacement therapy (ERT) is an approved treatm...
Autores principales: | Eisengart, Julie B., Jarnes, Jeanine, Ahmed, Alia, Nestrasil, Igor, Ziegler, Richard, Delaney, Kathleen, Shapiro, Elsa, Whitley, Chester |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622996/ https://www.ncbi.nlm.nih.gov/pubmed/28983455 http://dx.doi.org/10.1016/j.ymgmr.2017.07.012 |
Ejemplares similares
-
Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome
por: Shapiro, Elsa G., et al.
Publicado: (2018) -
A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutation
por: Ahmed, Alia, et al.
Publicado: (2019) -
Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study
por: Nestrasil, Igor, et al.
Publicado: (2017) -
Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes
por: Eisengart, Julie B., et al.
Publicado: (2019) -
Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review
por: Pillai, Nishitha R., et al.
Publicado: (2022)